Laredo, V.; Sostres, C.; García, S.; Carrera-Lasfuentes, P.; Revilla-Marti, P.; Lanas, Á.
No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy. J. Clin. Med. 2020, 9, 1526.
https://doi.org/10.3390/jcm9051526
AMA Style
Laredo V, Sostres C, García S, Carrera-Lasfuentes P, Revilla-Marti P, Lanas Á.
No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy. Journal of Clinical Medicine. 2020; 9(5):1526.
https://doi.org/10.3390/jcm9051526
Chicago/Turabian Style
Laredo, Viviana, Carlos Sostres, Sandra García, Patricia Carrera-Lasfuentes, Pablo Revilla-Marti, and Ángel Lanas.
2020. "No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy" Journal of Clinical Medicine 9, no. 5: 1526.
https://doi.org/10.3390/jcm9051526
APA Style
Laredo, V., Sostres, C., García, S., Carrera-Lasfuentes, P., Revilla-Marti, P., & Lanas, Á.
(2020). No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy. Journal of Clinical Medicine, 9(5), 1526.
https://doi.org/10.3390/jcm9051526